Community pharmacy integration within the primary care pathway for people with long-term conditions: a focus group study of patients', pharmacists' and GPs' experiences and expectations.

Publisher: BioMed Central Country of Publication: England NLM ID: 100967792 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2296 (Electronic) Linking ISSN: 14712296 NLM ISO Abbreviation: BMC Fam Pract Subsets: MEDLINE

Original Publication: London : BioMed Central, [2000-2021]

Attitude of Health Personnel* ; Attitude to Health* ; General Practitioners* ; Pharmacists*; Community Pharmacy Services/*organization & administration ; Primary Health Care/*organization & administration; Asthma/therapy ; Chronic Disease ; Diabetes Mellitus/therapy ; England ; Female ; Focus Groups ; Humans ; Male ; Patient Care Team ; Pulmonary Disease, Chronic Obstructive/therapy ; Qualitative Research

Background: This study aimed to use marketing theory to examine the views of patients, pharmacists and general practitioners (GPs) on how community pharmacies are currently used and to identify how community pharmacy services may be better integrated within the primary care pathway for people with long-term conditions (LTCs).
Methods: A qualitative research design was used. Two focus groups were conducted with respiratory patients (n = 6, 5) and two with type 2 diabetes patients (both n = 5). Two focus groups were held with pharmacists (n = 7, 5) and two with GPs (both n = 5). The "7Ps marketing mix" ("product", "price", "place", "promotion", "people", "process", "physical evidence") was used to frame data collection and analysis. Data was analysed using thematic analysis.
Results: Due to the access and convenience of community pharmacies ("place"), all stakeholder groups recommended using community pharmacies over GP practices for services such as management of minor ailments, medication reviews and routine check-ups for well managed LTCs ("product"). All stakeholder groups preferred pharmacy services with clear specifications which focused on specific interventions to reduce variability in service delivery and quality ("process"). However, all stressed the importance of having an appropriate system to share relevant information, allowing pharmacists and GPs two-way flow ("process"). Pharmacists and GPs mentioned difficulties in collaborating with each other due to inter-professional tensions arising from funding conflicts, which leads to duplication of services and inefficient workflow within the primary care pathway ("people"). Patients and GPs were sometimes doubtful of community pharmacies' potential to expand services due to limited space, size and poor quality consultation rooms ("physical evidence"). However, all stakeholder groups recommended promoting community pharmacy services locally and nationally ("promotion"). Patients felt the most effective form of promotion was first-hand experience of high quality pharmacy services and peer word-of-mouth. The added value of using pharmacy services was faster access and convenience for patients, and freeing up GPs' time to focus on more complex patients ("value").
Conclusions: Using the 7Ps marketing mix highlighted factors which could influence utilisation and integration of community pharmacy services within the primary care pathway for patients with LTCs. Further research is needed to identify their relative importance.

Int J Pharm Pract. 2013 Jun;21(3):151-60. (PMID: 23418926)
Int J Pharm Pract. 2015 Apr;23(2):150-3. (PMID: 24909457)
Med Decis Making. 2008 Sep-Oct;28(5):781-92. (PMID: 18556638)
Res Social Adm Pharm. 2009 Dec;5(4):305-18. (PMID: 19962674)
Res Social Adm Pharm. 2013 Nov-Dec;9(6):949-57. (PMID: 23506650)
Res Social Adm Pharm. 2018 Feb;14(2):127-137. (PMID: 28392257)
Br J Gen Pract. 2016 Apr;66(645):e248-57. (PMID: 26965025)
Int J Pharm Pract. 2015 Apr;23(2):121-30. (PMID: 24905628)
Res Social Adm Pharm. 2016 Nov - Dec;12(6):966-989. (PMID: 26806858)
Res Social Adm Pharm. 2017 Jan - Feb;13(1):17-38. (PMID: 27033426)
Eur J Health Law. ;23(5):435-52. (PMID: 29210245)
BMJ Open. 2017 Oct 10;7(10):e017843. (PMID: 29018074)
J Palliat Med. 2012 Mar;15(3):317-21. (PMID: 22339286)
J Diabetes Sci Technol. 2009 Jan;3(1):175-9. (PMID: 20046662)
Int J Pharm Pract. 2017 Apr;25(2):121-132. (PMID: 27324310)
Health Soc Care Community. 2019 May;27(3):565-598. (PMID: 30047617)
BMJ Open. 2017 Mar 3;7(3):e013451. (PMID: 28259852)
BMC Public Health. 2011 Jul 21;11:582. (PMID: 21777456)
Res Social Adm Pharm. 2014 Mar-Apr;10(2):272-84. (PMID: 23089293)
Res Social Adm Pharm. 2012 Mar-Apr;8(2):122-32. (PMID: 21511541)
Res Social Adm Pharm. 2012 Jan-Feb;8(1):36-46. (PMID: 21454138)
Int J Clin Pharm. 2014 Feb;36(1):154-62. (PMID: 24293306)
Am J Surg. 2001 Jan;181(1):1-7. (PMID: 11248166)
Health Policy. 2008 Dec;88(2-3):258-68. (PMID: 18468713)
Health Policy. 2015 May;119(5):628-39. (PMID: 25747809)
BMJ Open. 2017 Sep 5;7(9):e015471. (PMID: 28877940)
Res Social Adm Pharm. 2014 Jan-Feb;10(1):58-71. (PMID: 23608701)
Can Pharm J (Ott). 2014 Jul;147(4):209-32. (PMID: 25360148)
Res Social Adm Pharm. 2018 Nov;14(11):1043-1057. (PMID: 29331530)
Health Expect. 2017 Oct;20(5):929-942. (PMID: 28105781)
Health Soc Care Community. 2008 Jul;16(4):363-9. (PMID: 18613912)
BMJ Open. 2015 Jul 10;5(7):e006934. (PMID: 26163029)
J Am Pharm Assoc (Wash). 2003 Mar-Apr;43(2):173-84. (PMID: 12688435)
Adm Policy Ment Health. 2015 Sep;42(5):533-44. (PMID: 24193818)
Res Social Adm Pharm. 2017 Jan - Feb;13(1):1-16. (PMID: 26898951)
BMJ. 2017 Apr 4;357:j1678. (PMID: 28377430)
Health Expect. 2018 Apr;21(2):409-428. (PMID: 29114971)
Int J Pharm Pract. 2015 Dec;23(6):399-406. (PMID: 25712253)

Keywords: Collaboration; Community pharmacy; General practice; General practitioners; Integration; Long-term condition; Patients; Pharmacists; Primary care

Date Created: 20190210 Date Completed: 20200210 Latest Revision: 20231005

20240829

PMC6368723

10.1186/s12875-019-0912-0

30736732